Latest Content

Dr. Andrew Ip answers common lymphoma questions, from diagnosis and treatment options to CAR T-cell therapy, side effects and hope for patients.

Bristol Myers Squibb reports positive results from a phase 2 trial of investigational CAR T-cell therapy arlo-cel in relapsed multiple myeloma.

Hargitay shared her thoughts with CURE regarding her father’s journey, her motivation for speaking out now, and the key message she wants to convey to patients today.

A new study found alcohol-attributable cancer deaths in the U.S. rose from 11,361 in 1990 to 23,126 in 2023, with men and older adults most affected.

Cancer survivor Brynn Forlizzi and caregiver Teddy Aaron created Soothe Note, an app designed to help cancer patients and caregivers manage care.

My multiple myeloma nurse case manager sat in on every appointment, helped me appeal an insurance denial and made sure I never felt like just a number.

Dr. Doured Daghistani discusses how childhood cancer treatment, survivorship care and immunotherapy have evolved this Childhood Cancer Awareness Month.

My daughter was 27 when breast cancer forced a decision about her fertility in days, and I keep thinking about the young women who can't afford that choice.

Explore how personalized treatment, immunotherapy, AI and other advances are transforming cancer care, with insights from Dr. Manmeet Ahluwalia.

Two and a half years into cancer treatment, my nurse Jenny Gnoza still greets me with a smile, steadies my nerves and finds the vein everyone else misses.

AI is changing breast cancer screening, helping doctors detect cancer and predict future risk. Learn what AI mammography means for patients.

FDA grants accelerated approval to camizestrant for certain advanced breast cancers with ESR1 mutations, offering a new treatment option.

Cancer can change, hide from the immune system and escape treatment, making effective therapy about more than targeting cancer cells alone.